Article
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Health Canada approves Biocon's Yesafili, biosimilar to Eylea
3 Things You Should Know About Interventional Glaucoma Comanagement
Nicox completes phase 3 Denali trial of NCX 470 in open-angle glaucoma or ocular hypertension
Patient-Centered Treatment Strategies in the Management of nAMD and DME
Nanoscope Therapeutics forms Vision Advisory Committee
Sanaregen Vision Therapeutics invites prospective investors to reserve stock shares